Sarah Wright, D.O., neuromuscular neurologist at Children’s National Hospital (IMAGE)
Caption
Hiram, 5, receives the first gene therapy for the treatment of pediatric patients with Duchenne muscular dystrophy (DMD), Approved by the FDA
Credit
Children's National Hospital
Usage Restrictions
This image is copyrighted and may be used with fair credit to Children's National Hospital.
License
Original content